ライフサイエンスコーパス: year

1 nrolled participants is 21 years (range 0-93 years).

2 re potentials) and time horizons (20 and 100 years).

3 ppression for 2 months, or suppression for 1 year.

4 atients discharged, 3461 (20%) died within 1 year.

5 m the lives of around 1.7 million people per year.

6 s were discharged home and survived beyond 1 year.

7 9 million commercially insured patients per year.

8 has attracted increasing attention in recent years.

9 49 (range, 18-86) years, and 62% were >= 40 years.

10 to spring transition than in other recorded years.

11 be an important research focus in the coming years.

12 Mean age was 40.5 years.

13 having increased sevenfold over the past 75 years.

14 with a median type 2 diabetes duration of 16 years.

15 9) and heparin (n=793) treated patients >=75 years.

16 Median age at HCT was 1.2 years.

17 displaced at least once in the previous five years.

18 ty for systematic reviews in the next 1 to 2 years.

19 mization and were followed for a mean of 3.5 years.

20 affected individuals at a median age of 22.5 years.

21 ) in adolescents and young adults aged 18-39 years.

22 s were included, with mean age 71.4 +/- 11.7 years.

23 t has been intensively bred over the last 60 years.

24 riod spanning four or five cycles of ~20,000 years.

25 andomization, and the mean follow-up was 4.6 years.

26 jected to produce a gain of 318 million life-years.

27 me and ASD-related social behaviors at age 3 years.

28 the field of asymmetric catalysis in recent years.

29 mples can predict allergy status at age 4(+) years.

30 corresponding to 22 deaths per 1,000 person-years.

31 ped symptoms during follow-up of 2.8 +/- 3.0 years.

32 (CMT) and the presence of fluid over the 10 years.

33 a-cell function, and adiponectin at age 11.5 years.

34 were identified from five countries over 26 years.

35 , and 0.46 (CI, 0.25 to 0.86) for 10 to 17.4 years.

36 l dependence at 3 months after onset (RR per year 0.983; 95% CI 0.968-0.998; p = 0.002 for trend).

37 copy were 0.55 (CI, 0.35 to 0.86) for 0 to 5 years, 0.54 (CI, 0.38 to 0.77) for 5.1 to 10 years, and

38 D rates per 1,000 person-years: age 18 to 24 years, 0.64; age 25 to 30 years, 0.65; men, 1.04; women,

39 ears: age 18 to 24 years, 0.64; age 25 to 30 years, 0.65; men, 1.04; women, 0.36; Blacks, 0.90; White

40 after clinically evaluated every 2-4 months (years 1-2), then every 6 months (years 3-5).

41 te the GoM open (- 0.06 +/- 0.45 mol C m(-2) year(-1)) and coastal (- 0.03 +/- 1.83 mol C m(-2) year(

42 1)) and coastal (- 0.03 +/- 1.83 mol C m(-2) year(-1)) ocean are approximately neutral in terms of an

43 of 3.1 (95% CI, 2.7-3.6) and for 10 or more years, 1.5 (95% CI, 1.4 to 1.6, P < .001).

44 mean (SD) age of the cohort was 60.6 (16.2) years, 103 (52.3%) were male, and 156 (82.1%) were black

45 e marrow cultures in southern India, over 26 years (1991-2016).

46 More than 75% of the pixels of FS at years 2 and 5 were preceded by pixels of baseline MNV.

47 incidence was also lower for those age >= 30 years (2.8%; 95% CI, 2.3 to 3.4) at first TC diagnosis t

48 2-4 months (years 1-2), then every 6 months (years 3-5).

49 the curve (mm Hgxyears) from baseline up to year 30 examination.

50 Gait and cognition were assessed at the year 30 examination.

51 nts (15-19 years) and 696 young women (20-24 years), 31.7% (95% confidence interval [CI] 29.5-34.1),

52 thnically diverse pregnant women (aged 20-45 years-33% primiparous, 37% biparous, 30% multiparous) wh

53 c resection were randomized (mean age = 62.8 years; 57% male; body-mass-index = 27.9).

54 We recruited 1121 women aged 30-65 years, 586 of whom were HIV-negative and 535 HIV-positiv

55 4) at first TC diagnosis than those age < 30 years (6.0%; 95% CI, 5.0 to 7.1).

56 25.0 per 1000 person-years; absolute RD at 5 years, 6.2%; 95% CI, 2.2%-10.4%; HR, 1.51; 95% CI, 0.97-

57 Association functional classes III/IV (5.2%/year); 67% have survived, including 31 with heart transp

58 Mean age was 42 years (range, 24-73 years); 69% were BRCA1+, 30% were BRCA2+, and 2% had bot

59 Of 1,239 eligible patients (61 +/- 18 years, 80% men), 1,072 (86%) had pure AR, and 167 (14%)

60 [CI], 1754-1789) and 303 per 100 000 person-years (95% CI, 295-310), respectively, between 2013 and

61 sepsis in adults was 1772 per 100 000 person-years (95% confidence interval [CI], 1754-1789) and 303

62 incidence rate, 42.5 vs 25.0 per 1000 person-years; absolute RD at 5 years, 6.2%; 95% CI, 2.2%-10.4%;

63 terest in genetic testing as a PLD: age >=35 years (adjusted odds ratio [aOR], 1.75; 95% confidence i

64 iety-depression symptoms between ages 3 to 8 years (adjusted odds ratio, 0.73; 95% confidence interva

65 ients with advanced cancer, aged at least 18 years, admitted to the palliative and supportive care un

66 s from 347 of 808 eligible first- and second-year adult nephrology fellows were examined (response ra

67 ses (ie, had at least two viral loads in the year after end of pregnancy).

68 malized peak VO2 <=60% and VE/VCO2 >=34 at 1 year after HTx are associated with the development of CA

69 overall mortality (cumulative incidence at 1 year after operation: 20.0% for uncemented fixation vs 2

70 Despite similar weight reductions 1 year after surgery (44.6% vs. 46.6%), 8 diabetes remitte

71 t computed tomographic imaging 30 days and 1 year after transcatheter aortic valve replacement (TAVR)

72 263 KTRs with grafts functioning at least 1 year after transplantation.

73 ollow-up examination at the end of the first year after treatment completion combined with 12 months

74 reased from 0.0 (95% CI, 0.0-2.9)/100 person-years after ART in Fiebig I to 15.9 (7.6-29.2) in Fiebig

75 Evaluation of clinical long-term results 20 years after connective tissue grafting (CTG) or guided t

76 es indicating increased disability), at 6-10 years after disease onset, assessed with a linear mixed-

77 report facial retransplantation in a man, 8 years after his first facial transplantation because of

78 cks in 39 patients occurred most commonly <5 years after implant (54%) and decreased in frequency wit

79 ter-year during the 3 years before and the 3 years after individuals moved.

80 3-2.31) in adults aged 55 years and older, 5 years after PCV10 introduction.

81 ce of herpes zoster, peaking in adults 15-35 years after the start of varicella vaccination.

82 1,301, intervention: n = 1,357), the other 2 years afterwards in 2016 (control: n = 996, intervention

83 subgroups (e.g., CVD rates per 1,000 person-years: age 18 to 24 years, 0.64; age 25 to 30 years, 0.6

84 arding the Mid-UP period (MUP, 33,000-24,000 years ago), which encompasses a pan-European cultural mo

85 Since its discovery 150 years ago, the neural crest has intrigued investigators

86 diseases since they became available over 60 years ago.

87 After some years agonizing by serial expert committees, the Nationa

88 atmospheric lead (Pb) spanning the last 4000 years, an effective indirect proxy for reliably assessin

89 Pacemaker dependency at 30 days and 1 year and all-cause mortality during follow-up were evalu

90 this analysis, the mean (SD) age was 48 (19) years and 25 939 (50.1%) were women; 43.2% were non-Hisp

91 d HPV testing at age 35 years, or at ages 35 years and 45 years, with scale-up to 45% coverage by 202

92 en diagnosed with breast cancer at age <= 40 years and enrolled patients between 2006 and 2016 (N = 1

93 l shifts after forest loss extended up to 50 years and increased with species' generation time.

94 d excellent insights into its frequency over years and indicated its presence in 94.1 and 93.7% of li

95 re lost to history for more than one hundred years and it is time to bring her back.

96 (31 females) with mean age of 48.0 +/- 18.0 years and mean follow-up of 78.6 +/- 42.2 months were in

97 ties and for the Medicare population aged 65 years and older across 3,113 US counties, respectively.

98 h stunting and overweight in children aged 4 years and older by providing school meals with improved

99 nths, and 1.90 (1.53-2.31) in adults aged 55 years and older, 5 years after PCV10 introduction.

100 nce of four or fewer cases per 100 000 women-years and ten or fewer cases per 100 000 women-years, an

101 sterone levels by age in youths aged 6 to 20 years and the onset and magnitude of divergence in level

102 rted ever having sex: 326 adolescents (15-19 years) and 696 young women (20-24 years), 31.7% (95% con

103 t-neonatal (age 28-364 days), child (age 1-4 years), and under-5 mortality rates (U5MRs) for each eth

104 Injury Severity Score, postgraduate training year, and days since training occurred.

105 years, 0.54 (CI, 0.38 to 0.77) for 5.1 to 10 years, and 0.46 (CI, 0.25 to 0.86) for 10 to 17.4 years.

106 Their mean age was 54 years, and 58% were women.

107 The median age was 49 (range, 18-86) years, and 62% were >= 40 years.

108 months, ages 3-12 months, ages 12 months-6.5 years, and ages 6.5-11.5 years) with fasting glucose, in

109 ars and ten or fewer cases per 100 000 women-years, and an 85% or greater reduction in incidence.

110 fic associations were notable: t-tau 8 to 16 years, and Nf-L and GFAP 4 to 8 years prior to clinical

111 have been extensively studied in the past 5 years, are mostly confined to a six faceted hexahedron (

112 ire score >=2) per quarter-year during the 3 years before and the 3 years after individuals moved.

113 eoccurrence in at least three-fourths of the years between 1980 and 2018, with 0.16 Mkm(2) of this ar

114 rom The Malaysian Cohort (TMC) aged 35 to 70 years between 2006 and 2012.

115 yses suggest an average window of over three years between the development of high-grade dysplasia an

116 nts have become more common in the past five years, but few studies concern the factors that control

117 gnosis continued to be on the rise in recent years, but who is diagnosed changed during the study per

118 In recent years, carbon black has been re-discovered in the design

119 ificantly lower rate and hazard of MACE at 5 years compared with no PCI (31.5% vs 39.1%; hazard ratio

120 Nonetheless, in recent years considerable efforts have ensued to characterize a

121 N(2) O emissions (1.84 Pg CO(2) -equivalent/year) could reduce mitigation potential of terrestrial n

122 Five-year cumulative incidence of oncologic and nononcologic

123 shold of US$500 per disability-adjusted life-year (DALY) averted for our main analysis.

124 eated multivariable regression models at the year, day, and visit level after adjustment for characte

125 ively, between 2013 and 2016, with a year-on-year decrease in incidence.

126 cause many coral species spawn only once per year during a narrow temporal window, sample processing

127 Health Questionnaire score >=2) per quarter-year during the 3 years before and the 3 years after ind

128 In recent years during enhanced hostility periods, the population

129 d for 20 of those hives for 6 weeks for both years, during commercial pollination.

130 enhanced brain MRI performed approximately 9 years earlier (Figs 1-5).

131 rated to Canada from the Middle East several years earlier and had no medical history of note; in par

132 This 20-year epidemiological study of all EGS hospital episodes

133 ear; glargine group, 0.46 events per patient-year; estimated rate ratio, 1.09; 95% CI, 0.45 to 2.65).

134 h a median follow-up of 44 months (26-53), 4-year event-free survival was 59% (95% CI 48-73); 69% (54

135 Four-year event-free survival, relapse-free survival, and ove

136 incident CRE cases with concurrent or prior year facility stays were identified; cases were attribut

137 sthma from 11 European countries within a 20-year follow-up (ECRHS and SAPALDIA cohorts).

138 e aphasia) that had undergone baseline and 1-year follow-up MRI and flortaucipir PET.

139 rtiles 3 and 4 for plasma sTNFR1 died over 4-year follow-up.

140 up to 6.3 years longer life for men and 7.6 years for women; however, not all lifestyle risk factors

141 e chemotherapy had a more than 97% rate of 8-year freedom from distant recurrence, and improvements w

142 dard error) tonnes of carbon per hectare per year from the breakdown of soil organic matter.

143 scovery and development, which usually takes years from start to finish.

144 s, and average diagnostic delay is up to 5-6 years from symptom onset.

145 In recent years, genome-wide association studies have shed light o

146 e low (icodec group, 0.53 events per patient-year; glargine group, 0.46 events per patient-year; esti

147 t claim at least a million human lives every year globally.

148 Studies in recent years have uncovered the crucial function of neuroimmune

149 TIA: 2.32 versus 0.75 events per 100 patient-years (hazard ratio [HR], 3.05 [95% CI, 1.65 to 5.62]; P

150 CVD (n = 1386 events; median follow-up, 25.2 years; hazard ratio [HR], 1.06 [95% CI, 0.89-1.26]), HF

151 Using 100-year historic daily precipitation data from six stations

152 Each year in the United States, influenza causes illness in 9

153 tages for the 43% of children younger than 5 years in low-income and middle-income countries who have

154 an independent predictor of mortality at 10 years in patients with complex coronary artery disease.

155 icted cognitive performance over 1, 2, and 4 years in patients with PD.

156 4 544 physicians (76.1% men, 60.1% with >=20 years in practice, 11.9% in rural location, 26.8% hospit

157 ntative sample of US adults aged at least 40 years in the National Health and Nutrition Examination S

158 (NSPN), a cohort of young people (aged 18-29 years) in the United Kingdom, who provided questionnaire

159 ecipitants occurred with postoperative AF (5-year incidence 32% in cardiac surgery and 39% in noncard

160 for inpatient FA in patients older than 3.8 years included the lack of availability of outpatient ul

161 , 23 227 patients (58% female; median age 34 years [interquartile range 28-41]) were ART-eligible at

162 At enrolment, the median age was 15 years (IQR 14-17), 52% of adolescents were female, 81% w

163 Of 614 patients (median age 69 years, (IQR 25) and 62% male), 381 (62%) had been discha

164 about 860 +/- 160 kilotonnes of nitrogen per year) is limited by a spatial disconnect between high-de

165 oup (hazard ratio 0.69, 95% CI 0.58-0.82); 8-year landmark overall survival rates were 37% (95% CI 31

166 cally develop coronary heart disease several years later than men.

167 firmed in another Boston Terrier presented 2 years later with a similar clinical picture.

168 hier lifestyle was associated with up to 6.3 years longer life for men and 7.6 years for women; howev

169 Of the 1624 women randomized (mean age, 30.4 years, mean body mass index, 39.5), 1608 (99%) completed

170 atients who underwent TAVR (mean age, 81+/-8 years, mean Society of Thoracic Surgeons score, 4.9 [3.3

171 Over a median follow-up of 10.2 years, mortality was highest for myocardial injury (45.6

172 For several years, most studies have focused on pernicious anaemia o

173 eriod and 10-fold lower during the follow-up year (n = 18, P = .03).

174 In addition, in younger (4-6 years, n = 67), but not older (6-8 years, n = 70) childr

175 nger (4-6 years, n = 67), but not older (6-8 years, n = 70) children, habitual sleep duration was rel

176 dult contacts developed incident TB within 1 year of index patient diagnosis.

177 pression of PD-1 and TIGIT, within the first year of infection.

178 A follow-up assessment at age 6-10 years of a multicentre European birth cohort based was u

179 on at >=2 years of age over horizons up to 8 years of age (area under the receiver operating characte

180 on-based study in Iceland, children under 10 years of age and females had a lower incidence of SARS-C

181 dramatically improves T1D prediction at >=2 years of age over horizons up to 8 years of age (area un

182 uble-blinded trial, 444 adults 60 through 64 years of age were randomized to receive either a single

183 Patients 10 to 17 years of age who had received stable lipid-lowering trea

184 oms (<=7 days from symptom onset [DSO], >=18 years of age) were utilized to compare Veritor with the

185 BR criteria per patient, including 60.7% >75 years of age, 34.1% on anticoagulants, and 14.7% with re

186 a prospective cohort study of children, 3-18 years of age, with CAP from 2016 to 2017.

187 During the past 85 years of antibiotic use, we have learned a great deal ab

188 During up to 21 years of follow-up, 30,389 (38%) participants died, corr

189 After 440 person-years of follow-up, 44% of YBMSM initiated PrEP through

190 In 47.5 million person-years of follow-up, 49,955 (2.3%) women were diagnosed w

191 Overall, 356 individuals completed 20 years of follow-up.

192 nts go on to develop secondary MDS/AML by 10 years of follow-up.

193 MACE within 5 years of imaging was adjudicated.

194 We combine 36 years of PM(2.5) concentrations measured over ~8.6 milli

195 After 50 years of research in computer-aided diagnosis, there is

196 hose properties remain uncertain, even after years of study.

197 xtinction process during the last 20 million years of the Late Cretaceous.

198 ive unvaccinated women and men aged 16 to 25 years old were recruited from 119 public primary care un

199 by increased use in patients greater than 12 years old.

200 A 69-year-old female with a PEG in position and in use for mo

201 A 37-year-old male with no relevant history presented to the

202 History A 70-year-old man had a posterior left thigh lesion confirmed

203 Per each 10-year older age group, the average RNFL thickness was 2.5

204 rolled trial we sequentially enrolled 1.5-45 year-olds (N=148) into four age-descending groups, rando

205 ups, with highest relative risks among 20-39 year-olds (respective aRRs 1.79, 2.33, 1.92; p-values <=

206 must undergo endoscopic evaluation after 1-3 years on a gluten-free diet to evaluate improvements in

207 impact of educational attainment (schooling years) on a variety of disease and life-expectancy outco

208 as assessed for eligibility (HIV+, age >= 14 years, on ART >6 months, not acutely ill, CD4 count not

209 respectively, between 2013 and 2016, with a year-on-year decrease in incidence.

210 ia, analyzing data from participants aged 40 years or older in the National Health Insurance Database

211 cal screening involved HPV testing at age 35 years, or at ages 35 years and 45 years, with scale-up t

212 In recent years, organic electronic materials have been shown to b

213 BRAF mutation status and as predictors of 5-year OS in patients with advanced-stage CRC.Keywords: Ab

214 ntly among ELN risk groups, with estimated 5-year OS probabilities of 0.63, 0.43, and 0.33 for favora

215 ize, and examination of only patients with 1-year outcome data.

216 With mean follow-up of 4.8 years (range, 1-7 years), outcomes were resolution of exudation or prolife

217 Excluding 2 postoperative deaths, 1- and 5-year overall survival (OS) and recurrence-free survival

218 Collectively, the 5-year overall survival estimate of the 16 062 patients in

219 a median follow-up of 70 months, rates of 5-year overall survival were 54% in the laparoscopic group

220 L thinning in uninjected eyes was -0.620 mum/year (P = .029).

221 9.7% of patients at <5 years to 3.8% at >=10 years, P=0.02).

222 an +/- SD age: 67.8 +/- 8.9 vs. 66.1 +/- 8.2 years; p < 0.001) and more likely to have diabetes melli

223 white European ancestry, aged 45 through 79 years, participating in the Atherosclerosis Risk in Comm

224 All patients were followed up over a 1-year period (study end date, March 31, 2019).

225 t 2472 DALYs (95% UI -888 to 7801) over a 10-year period and is expected to be cost-saving compared w

226 nce (average number of worms/fish) over a 53 year period from 1962 to 2015 and no significant change

227 in Pseudoterranova spp. abundance over a 37 year period from 1978 to 2015.

228 0-2018 SWNA drought was the second driest 19-year period since 800 CE, exceeded only by a late-1500s

229 of 2 or 3 treatment modifications over the 4-year period suggest an unmet need for glaucoma therapies

230 During the 15-year period, 207 patients underwent LT after Y90.

231 esence of right whales in MB over a nearly 6 year period, July 2007-April 2013, a time of both rapid

232 no intervention reduced perpetration of past-year physical IPV.

233 During pregnancy and the first year postpartum, 64% (n = 19,344) and 13% (n = 3,994) di

234 We estimated the 10-year predicted risk of CVD using the American College of

235 Prevalent diagnoses in the year prior to the inpatient admission; healthcare contac

236 during a five month stay in Indonesia seven years prior to admission.

237 -tau 8 to 16 years, and Nf-L and GFAP 4 to 8 years prior to clinical AD.

238 mic analyses have been established in recent years, processing the resulting radiomic datasets remain

239 he median age of enrolled participants is 21 years (range 0-93 years).

240 After a median follow-up of 11 years (range 1 mo-25 yrs), symptomatic recurrence was ob

241 With mean follow-up of 4.8 years (range, 1-7 years), outcomes were resolution of ex

242 Mean age was 42 years (range, 24-73 years); 69% were BRCA1+, 30% were BR

243 iation (SD) of the patients was 28.4 +/- 5.6 years (range: 18-43).

244 480,940 middle-aged adults (median age of 58 years [range 38-73], 46% male, 95% white) were analysed

245 tudied at 2 weeks post-injury (mean age 52.8 years, range 22-77; 63 females; 64 right hemispheres).

246 ive MRI examinations (median patient age, 56 years; range, 25-94 years), resulting in a positive pred

247 s was stable and persistently compromised [4-year relative survival and 95% confidence interval: 0.87

248 Consequently, in recent years research efforts have been directed towards modeli

249 ment (1951, 290, and 31 cases/100 000 person-years, respectively; P < .001).

250 cal therapy was similar (1.3 vs. 2.1 vs. 1.6 years, respectively; P = 0.53).

251 d earlier than women (45+/-14 versus 49+/-16 years, respectively; P=0.04).

252 (median patient age, 56 years; range, 25-94 years), resulting in a positive predictive value for bio

253 In this 10-year retrospective review, consecutive patients who unde

254 A 5-year retrospective single-center study in all adult pati

255 cardiomyopathy and a low- or intermediate 5-year risk of sudden cardiac death underwent cardiac magn

256 Absolute 10-year risks of outcomes were as follows: HF: 3.18% (95% c

257 This year's Canada Gairdner International Prize is shared by

258 ibodies that using 3- to 15-month or 2- to 3-year samples can predict allergy status at age 4(+) year

259 nificantly reduced male perpetration of past-year sexual IPV (AOR: 0.73; 95% CI: 0.56-0.94, p = 0.014

260 hat every day about 1600 youth aged 12 to 17 years smoke their first cigarette and that about 5.6 mil

261 n Americans, and 90 Hispanics with >=20 pack-years smoking were resequenced for the identification of

262 In the 15-year study period, the overall prevalence of severe skin

263 f glacial terminations over the past 640,000 years suggests pacing by Earth's climatic precession, wi

264 The corresponding 5-year survival for ER and esophagectomy were 53% versus 6

265 defined as follows: 1) ICU survivors; 2) one-year survivors reporting newly-acquired chronic pain; an

266 ing newly-acquired chronic pain; and (3) one-year survivors with pain who lived within 50 km from the

267 mong the 2,264 participants (mean age = 62.6 years), the geometric mean of 25OHD concentration was 66

268 After the first year, the risk of Guillain-Barre was not increased.

269 In recent years, the accelerating tempo of epizootic and zoonotic

270 After a median follow-up of 3.1 years, the achieved LDL-C concentrations were 64 mg/dL (

271 At 5 years, the incidence of major adverse cardiovascular and

272 Two-year therapy prevented a 1-month-of-life loss, and revea

273 During the last 2 years there has been a preponderance of data demonstrati

274 In the past year, there have been numerous advances in our understan

275 At 10 years, there were no measurable differences in outcomes

276 e study of 3120 diabetic patients aged >= 60 years, those taking metformin were less likely to have a

277 me from implant (from 9.7% of patients at <5 years to 3.8% at >=10 years, P=0.02).

278 Herein, we investigated one-year toxicity of non-surface modified silica nanoparticl

279 ed 100-fold lower than baseline during the 3 year-treatment period and 10-fold lower during the follo

280 We use hydrological modeling and new 1200-year tree-ring reconstructions of summer soil moisture t

281 tem production by 8.3% (NEP, 22.25 Pg CO(2) /year) under warming.

282 Sixty patients with VSD aged 12 to 60 years underwent cardiopulmonary exercise test and echoca

283 of adults with IDU histories reported prior-year use.

284 with SCA3/MJD were evaluated annually for 15 years using the International Cooperative Ataxia Rating

285 Graft loss at 1 month and 1 year was similar between groups (O:E = 0.65 vs 1.00, P =

286 the number with BCVA of 20/200 or worse at 2 years was 56 (9.4%).

287 Patient survival at 1, 5, 10, and 15 years was 97.4%, 93.0%, 89.4%, and 80.0%, respectively.

288 Children ages 6-13 years were frequently asymptomatic (39%) and had respira

289 Patients (aged >=16 years) who were being treated non-operatively for a prim

290 o 2 gigatonnes of carbon dioxide (CO(2)) per year with extraction costs of approximately US$80-180 pe

291 salvage radiotherapy (control) to 95% at 10 years with adjuvant radiotherapy.

292 Participants were 55 to 90 years with GA secondary to age-related macular degenerat

293 ier: NCT02953678), patients aged at least 12 years with grades II to IV steroid-refractory aGVHD were

294 ages 12 months-6.5 years, and ages 6.5-11.5 years) with fasting glucose, insulin, insulin resistance

295 Mean age was 74 years, with a median type 2 diabetes duration of 16 year

296 Dementia incidence was assessed over 3-5 years, with diagnosis according to the 10/66 Study diagn

297 at age 35 years, or at ages 35 years and 45 years, with scale-up to 45% coverage by 2023, 70% by 203

298 the first cause of disability-adjusted life years worldwide, yet most attention has focused on acute

299 ations of E-selectin and ICAM-1, obtained at year (Y) 7 (Y7) and Y15 examinations, with cardiac funct

300 aordinary eruptive sequences in at least 200 years, yet the trigger mechanism remains elusive(1).